A Glimpse Into The Expert Outlook On Health Catalyst Through 6 Analysts
A Glimpse Into The Expert Outlook On Health Catalyst Through 6 Analysts
通过6名分析师的眼光，了解对Health Catalyst的专业观点
Analysts' ratings for Health Catalyst (NASDAQ:HCAT) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
过去一个季度的Health Catalyst（纳斯达克：HCAT）的分析师评级从看好变为看淡，共有6位分析师提供。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格总结了分析师们最近的评级，揭示了过去30天内情绪的变化并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $12.0, a high estimate of $16.00, and a low estimate of $7.00. Highlighting a 7.69% decrease, the current average has fallen from the previous average price target of $13.00.
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Investigating Analyst Ratings: An Elaborate Study
分析师评级的调查：一项详尽的研究
A comprehensive examination of how financial experts perceive Health Catalyst is derived...
净资产收益率（ROE）：...
登录免费看全文
登录/注册